Physician profile
Keith A Aldinger
NPI 1235116633
$704.94
in general payments reported to CMS, 2019-2025
10 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.31 · 2020: $46.40 · 2022: $74.07 · 2023: $97.44 · 2024: $136 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $180.68 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $121.01 | 2022-2023 | |
| Novo Nordisk INC | $92.53 | 2019-2025 | Ozempic |
| Exact Sciences Corporation | $90.68 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $89.94 | 2024-2025 | Evenity, Prolia |
| Esperion Therapeutics, INC. | $37.60 | 2025 | Nexletol |
| Verity Pharmaceuticals INC. | $30.53 | 2025 | Tlando |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.63 | 2019 | |
| Abbvie INC. | $23.95 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Aldinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.